BEST PRACTICE
The evaluation of growth and the identification of growth hormone deficiency
Department of Child Life and Health, University of Edinburgh, Edinburgh, UK
Correspondence to:
For correspondence:
Professor Christopher Kelnar
Department of Child Life and Health, University of Edinburgh, 20, Sylvan Place, Edinburgh EH9 1UW, UK; chris@kelnar.com
Keywords: growth hormone; short stature
| The first 150 words of the full text of this article appear below. |
The assessment of child growth is a routine part of child health care worldwide.1 Growth monitoring is important in the early detection of disease in children and of particular value in detecting a wide variety of endocrine abnormalities in which poor growth may be the earliest, or only, sign of a problem.2 However, although measurement of height is regarded as an important component of paediatric care worldwide, national practices vary widely.3,4 Additionally, despite its widespread use, little is known about the diagnostic performance of growth monitoring in terms of its sensitivity and specificity for the detection of growth disorders and of its impact on child health.46 In the United Kingdom, this has resulted in the most recent recommendations from a UK National Health Service review which suggest that height monitoring in childhood should be reduced to a single measurement at the age of 5 years.7 In this article we discuss
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



